Metrogel-Vaginal

Pouchitis, Liver Abscess, Amebic, Lung Abscess + 53 more
Treatment
41 FDA approvals
20 Active Studies for Metrogel-Vaginal

What is Metrogel-Vaginal

MetronidazoleThe Generic name of this drug
Treatment SummaryMetronidazole is a prescription antibiotic used to treat various infections. It belongs to the nitroimidazole family of antibiotics and is effective in treating bacterial and parasitic infections, such as trichomoniasis, giardiasis, amebiasis, and gastrointestinal infections. Metronidazole is available as a pill, capsule, topical cream, and suppository. It has been used for decades to treat infections and continues to be an effective treatment option.
Flagylis the brand name
image of different drug pills on a surface
Metrogel-Vaginal Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Flagyl
Metronidazole
1963
449

Approved as Treatment by the FDA

Metronidazole, commonly known as Flagyl, is approved by the FDA for 41 uses including Abscess and Liver Abscess .
Abscess
Liver Abscess
Communicable Diseases
Bone and Joint Infections
Bacterial Endocarditis
Helicobacter Pylori Infection
Used to treat Helicobacter Pylori Infection in combination with Bismuth subsalicylate
Osteomyelitis
Abdominal Abscess
Abdominal Infection
Skin and skin structure infections
Gynaecological infection
Lung Abscess
Endometritis
Central Nervous System Bacterial Infections
Bacterial Meningitis
Pneumonia
intra-abdominal bacterial infections
hepatic abscess
Tubo-ovarian abscess
Lung Abscess
Curling Ulcer
Used to treat Duodenal Ulcer in combination with Bismuth subsalicylate
Lower respiratory tract infection bacterial
Bacterial Septicemia
Bacteria, Anaerobic
Bacterial Infections
Duodenal Ulcer
Used to treat Duodenal Ulcer in combination with Bismuth subsalicylate
Meningitis
Abscess, Intra-Abdominal
Empyema
asymptomatic Trichomoniasis
Exposure via partner
Endomyometritis
Bacterial Peritonitis
Central Nervous System Bacterial Infections
Empyema
Trichomonas Infections
Endometritis
Endometritis
Bacteria
Endocarditis, Bacterial
Communicable Diseases

Effectiveness

How Metrogel-Vaginal Affects PatientsMetronidazole is used to treat certain bacterial and parasitic infections, including amebiasis, trichomoniasis, and giardiasis. It is effective against most anaerobic bacteria, but not against facultative anaerobes or obligate aerobes. This is because it damages the DNA of the microbes it targets. It is important to be aware that taking metronidazole can cause convulsions and peripheral neuropathy, especially at higher doses. If these symptoms occur, the drug should be stopped immediately. Additionally, it has been found to be carcinogenic in mice and rats. The effects on humans
How Metrogel-Vaginal works in the bodyMetronidazole works by entering cells and breaking down into toxic metabolites. These metabolites can damage the DNA of certain organisms, like anaerobic bacteria and protozoans. Metronidazole is only toxic to these organisms because of the difference in their electron transport systems. When the nitro group of metronidazole is reduced by ferredoxin or flavodoxin, it creates toxic metabolites that can damage the DNA of the target organisms.

When to interrupt dosage

The dose of Metrogel-Vaginal is contingent upon the determined condition, including Exposure via partner, Skin and Curling Ulcer. The measure likewise differs depending on the method of delivery (e.g. Capsule or Vaginal) featured in the table beneath.
Condition
Dosage
Administration
Tubo-ovarian abscess
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
Uterine Cervicitis
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
Bacterial Septicemia
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
Trichomonas Vaginitis
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
Vaginitis
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
Bacterial Vaginosis
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
Bacterial Peritonitis
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
Communicable Diseases
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
post-surgical vaginal cuff infection
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
Giardiasis
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
Candida albicans
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
Inflammatory Papule
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
Vulvovaginitis
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
Pouchitis
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
Bacterial Meningitis
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
Exposure via partner
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
Sinusitis
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
Endocarditis, Bacterial
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
Operative Surgical Procedures
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous
Lockjaw
5.0 mg/mL, , 0.0075 mg/mg, 500.0 mg, 0.01 mg/mg, 7.5 mg/mL, 250.0 mg, 375.0 mg, 0.065 mg/mg, 125.0 mg, 10.0 %, 0.75 %, 1.0 %, 750.0 mg, 0.001 mg/mg, 200.0 mg, 400.0 mg, 100.0 mg/mL, 0.013 mg/mg, 0.5 mg/mg
Injection, solution, Injection, solution - Intravenous, Intravenous, , Gel, Gel - Topical, Oral, Tablet, Cream, Cream - Topical, Tablet - Oral, Topical, Lotion - Topical, Lotion, Vaginal, Gel - Vaginal, Capsule, Capsule - Oral, Kit, Suppository, Cream - Vaginal, Suppository - Vaginal, Tablet, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, film coated, extended release - Oral, Suppository - Rectal, Rectal, Tablet, coated - Oral, Tablet, coated, Kit - Oral, Tablet, film coated, extended release, Ointment, Ointment - Topical, Insert, Insert - Vaginal, Solution, Solution - Intravenous, Tablet, extended release, Injection - Intravenous

Warnings

Metrogel-Vaginal has three contraindications and should not be utilized if you are experiencing any of the conditions in the following table.Metrogel-Vaginal Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Metronidazole may interact with Pulse Frequency
Pregnancy Trimester, First
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Metronidazole may interact with Pulse Frequency
There are 20 known major drug interactions with Metrogel-Vaginal.
Common Metrogel-Vaginal Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be decreased when combined with Metronidazole.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be decreased when combined with Metronidazole.
Alectinib
Major
The metabolism of Alectinib can be decreased when combined with Metronidazole.
Alpelisib
Major
The metabolism of Alpelisib can be decreased when combined with Metronidazole.
Aminophylline
Major
The metabolism of Aminophylline can be decreased when combined with Metronidazole.
Metrogel-Vaginal Toxicity & Overdose RiskThe toxic dose of metronidazole in rats is 5000mg/kg. Overdosing on metronidazole can cause symptoms like nerve damage, brain toxicity, seizures, an unpleasant reaction if combined with alcohol, dark urine, a bad taste in the mouth, nausea, stomach pain, and dizziness, as well as a decrease in white blood cells. If someone overdoses on this drug, activated charcoal can help remove it from the body and poison control centers should be contacted for additional guidance.
image of a doctor in a lab doing drug, clinical research

Metrogel-Vaginal Novel Uses: Which Conditions Have a Clinical Trial Featuring Metrogel-Vaginal?

179 active studies are examining the potential of Metrogel-Vaginal to mitigate Curling Ulcer, Periodontitis and Central Nervous System Bacterial Infections.
Condition
Clinical Trials
Trial Phases
Lockjaw
0 Actively Recruiting
Uterine Cervical Erosion
0 Actively Recruiting
Gum Disease
3 Actively Recruiting
Phase 3, Not Applicable
Abdominal Infection
0 Actively Recruiting
Rosacea
0 Actively Recruiting
Balantidiasis
0 Actively Recruiting
Empyema
1 Actively Recruiting
Phase 4
Abdominal Abscess
2 Actively Recruiting
Phase 4, Phase 1, Phase 2
Bacteria
0 Actively Recruiting
Trichomonas Infections
0 Actively Recruiting
Vulvovaginitis
0 Actively Recruiting
Lung Abscess
0 Actively Recruiting
Pouchitis
4 Actively Recruiting
Phase 2, Phase 3, Early Phase 1, Phase 4
Atopic Dermatitis
10 Actively Recruiting
Phase 2, Phase 3, Phase 4
Acne Vulgaris
0 Actively Recruiting
Operative Surgical Procedures
0 Actively Recruiting
Liver Abscess, Amebic
0 Actively Recruiting
Trichomonas Vaginitis
2 Actively Recruiting
Phase 2, Phase 4
Amebic colitis
0 Actively Recruiting
Rosacea
2 Actively Recruiting
Early Phase 1, Phase 2

Metrogel-Vaginal Reviews: What are patients saying about Metrogel-Vaginal?

5Patient Review
10/5/2015
Metrogel-Vaginal for Vaginosis caused by Bacteria
I have BV because of the foul smell when I urinate. As much as I try avoiding to go to gyn, the only thing that takes care of this problem for me is this medicine. It works by the second day, but I take the full five day course 1x/day so it stays at bay for a while. The cottage cheese discharge while using the medicine is normal and I also experience light cramping after tbe third day til I am done with the medicine
5Patient Review
7/29/2019
Metrogel-Vaginal for Vaginosis caused by Bacteria
I just completed a five-day treatment of this medication and I'm already feeling so much better. I experienced some cramping on day three, as well as the discharge that indicates the medication is working, but those were really the only side effects I noticed.
4.3Patient Review
10/31/2018
Metrogel-Vaginal for Vaginosis caused by Bacteria
I experienced a lot of pain and cramping while using this treatment. I also had stomach issues and a lot of discharge. The burning sensations and pressure were also very unpleasant. Overall, I hope it worked but it was definitely not a pleasant experience.
4.3Patient Review
10/25/2022
Metrogel-Vaginal for Vaginosis caused by Bacteria
Some people will complain about anything, but the gel is actually working if you're experiencing clumping of your vaginal discharge. I've had wine while using it with no negative consequences, and it takes away BV after just five days. If you want to be productive, get your male partners treated for BV while you're getting treated yourself.
4Patient Review
2/4/2016
Metrogel-Vaginal for Vaginosis caused by Bacteria
I was pleasantly surprised that there wasn't any discomfort when inserting the medication. It didn't leak out, even when I was standing up (although I used it before bed and tried to stay lying down). Currently on day 4, symptoms for BV are gone, now just worried about a possible yeast infection after reading the reviews! Eating lots of yogurt in the meantime. Very happy with this product!
3.7Patient Review
6/27/2021
Metrogel-Vaginal for Vaginosis caused by Bacteria
I was prescribed this gel by my gyno to treat recurring bv. I used it once per week for six months as directed, but found that each time I did so, I would end up with a week of really heavy discharge afterwards. It was incredibly inconvenient and messy, so I stopped using it after the six months were up.
2.7Patient Review
3/12/2016
Metrogel-Vaginal for Vaginosis caused by Bacteria
I have now been using this gel for five days. I experience cramps every night, but they aren't too bad (a four out of ten on the pain scale). The white, wet discharge is really unpleasant though. I hope I don't get a yeast infection after I finish the treatment.
2.7Patient Review
8/3/2016
Metrogel-Vaginal for Vaginosis caused by Bacteria
I got bacterial vaginosis for the first time post-menopause. My doctor prescribed this gel to use for five nights before bed. It's easy to insert and didn't cause too much leaking when I wake in night time to go to bathroom, but one month later I got BV again. The second time my doctor prescribed this for me again, but it caused inflammation of my internal vaginal tissues, so she told me to stop it after day three. Will not use again.
1Patient Review
10/6/2019
Metrogel-Vaginal for Vaginosis caused by Bacteria
The cramps, anxiety, and depression I felt after taking this medication were absolutely unbearable. I ended up having to take a different medication (clindimyicin) and it worked much better.
1Patient Review
6/21/2020
Metrogel-Vaginal for Vaginosis caused by Bacteria
I unfortunately had an allergic reaction in the form of urticaria.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about metrogel-vaginal

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Metrogel VAG gel used for?

"This drugs is used to treat bacterial infections in the vagina. It works by stopping the growth of the bacteria."

Answered by AI

How long does it take for Metrogel to work for BV?

"Cigna Health states that most BV treatments will get rid of symptoms within two to three days, but it is recommended that you finish the treatment for BV within seven days."

Answered by AI

What are the side effects of Metrogel?

"If you experience any negative effects after taking this medication, such as a burning feeling, skin irritation, dryness, redness, metallic taste, nausea, or headache, tell your doctor or pharmacist right away."

Answered by AI

How do I use Metrogel for BV?

"If you are an adult, insert one 500 milligram tablet high into your vagina once a day in the evening for 10 or 20 days. If you are a child, your doctor will determine how much of the medicine you should use and how often you should use it."

Answered by AI

Clinical Trials for Metrogel-Vaginal

Image of UNC Chapel Hill in Chapel Hill, United States.

Intrapleural Enzyme Therapy for Pleural Infection

18+
All Sexes
Chapel Hill, NC
The goal of this clinical trial is to find out if giving certain medications once a day works just as well as giving them twice a day to treat infections around the lungs (called pleural infections). These medications-tissue plasminogen activator (tPA) and deoxyribonuclease (DNase)-are placed through a chest tube into the space between the lung and the chest wall to help clear out the infection. The investigators are trying to learn: * Does using the medicine once a day work just as well as using it twice a day? * Are there any differences in outcomes between patients who get the medicine once a day versus twice a day? * Does more or less fluid remain in the chest (seen on a chest x-ray) depending on how often the medicine is given? Participants will: * Have an infection around their lung and will already be getting normal hospital care, including a chest tube to drain the infected fluid around their lung. * Be asked to give permission to join the study. * Be randomly chosen (like flipping a coin) to get the medications either once a day or twice a day through the chest tube.
Phase 4
Waitlist Available
UNC Chapel HillJason Akulian, MD, MPH
Have you considered Metrogel-Vaginal clinical trials? We made a collection of clinical trials featuring Metrogel-Vaginal, we think they might fit your search criteria.Go to Trials
Image of Office of Dental Health, Department of Health and Senior Services in Jefferson City, United States.

Dental Care for Pneumonia Prevention

60 - 100
All Sexes
Jefferson City, MO
The goal of this study is to learn if dental infection control treatment delivered to older adult nursing home residents at their place of residence will result in : * improved dental health * reduced risk of pneumonia * better glucose control for diabetic patients compared to the pre-project dental and general health evaluations of residents and the pre-project facility incidence of pneumonia. Dental infection control treatment includes treating gum infections, stopping or slowing decay with fluoride, and assisting residents with effective tooth brushing and denture cleaning daily. Previous studies indicate dental infections can be inhaled and cause pneumonia or make diabetes worse. A shortage of dentists has limited care for nursing home residents. This project will allow dental hygienists and specially trained dental assistants to treat nursing home residents using telehealth methods (computers, cameras, internet, and telephone) to talk and work with dentists in different locations.
Recruiting
Has No Placebo
Office of Dental Health, Department of Health and Senior Services
Have you considered Metrogel-Vaginal clinical trials? We made a collection of clinical trials featuring Metrogel-Vaginal, we think they might fit your search criteria.Go to Trials
Image of UCSF in San Francisco, United States.

Moisturizers for Aging

65+
All Sexes
San Francisco, CA
This is a randomized, investigator-blinded, self-controlled pilot study of the physiologic response to topical moisturizers among older adults with dry skin. The overarching hypothesis is that skin barrier decline is an important source of chronic inflammation, and that skin barrier restoration with moisturizers can reduce serum biomarkers of inflammation. The primary objective is to determine the feasibility for a larger trial, and the secondary objectives are to determine the extent to which measures of serum inflammation, skin barrier function, and the skin microbiome change in response to moisturizers. Participants will be asked to apply one of two topical moisturizers that are widely available over the counter in the US (Vaseline® 100% pure petroleum jelly or CeraVe® moisturizing cream) once daily for 4 weeks to the front of the torso, buttocks, arms, and legs. Subjects will act as their own control (i.e. they will be asked to apply the study moisturizer they are randomized to for one intervention period (4 weeks) and not to apply topical moisturizers for the other 4- week intervention period). Participants will be randomized in a 1:1:1:1 ratio to one of 4 treatment groups: i. no intervention then CeraVe; ii. CeraVe then no intervention; iii. no intervention then Vaseline; iv. Vaseline then no intervention. At each visit (baseline, week 4, and week 8), participants will undergo skin barrier testing, skin microbiome sampling, and phlebotomy to measure serum inflammatory markers.
Phase 4
Recruiting
UCSFKatrina Abuabara, MD
Image of Loma Linda University Medical Center Troesh Medical Campus in Loma Linda, United States.

Endotracheal Suctioning for Procedural Pain

18+
All Sexes
Loma Linda, CA
The goal of this experimental study is to understand if endotracheal tube (ETT) suctioning increases pain and causes stress on the body in intubated adult ICU patients. These patients are already on ventilators, which means they need suctioning to keep their airways clear, but this procedure may be uncomfortable and cause stress. The main questions this study aims to answer are: Does ETT suctioning raise pain levels as measured by the Critical-Care Pain Observation Tool (CPOT)? Does ETT suctioning increase certain chemicals in the blood (hypoxanthine, xanthine, and uric acid) that show stress and lack of oxygen in the body? Researchers will compare patients who have ETT suctioning (intervention group) with those who do not have suctioning during the study period (control group) to see if there are differences in pain and blood markers of stress. Participants will: Have pain measured before and after suctioning using the CPOT. Have blood samples taken from an existing line at three time points: 5 minutes before, 5 minutes after, and 30 minutes after suctioning. Provide demographic information (like age, gender, and diagnosis) from medical records. This research will help improve how pain is managed for ICU patients who cannot speak for themselves, potentially leading to better pain relief methods in the future.
Recruiting
Has No Placebo
Loma Linda University Medical Center Troesh Medical CampusElizabeth Johnston Taylor, PhD, FAAN
Have you considered Metrogel-Vaginal clinical trials? We made a collection of clinical trials featuring Metrogel-Vaginal, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security